Chattem new products boost 1994 U.S. consumer sales 8% to $83 mil..
This article was originally published in The Tan Sheet
Executive Summary
CHATTEM NEW PRODUCTS BOOST 1994 U.S. CONSUMER SALES BY 8% to about $83 mil., the company announced in a Feb. 9 release. Chattem said incremental sales of recently acquired Benzodent and pHisoDerm were about $6.3 mil., while sales for the remainder of the consumer products division "were relatively flat." Chattem completed its acquisition of Benzodent from Procter & Gamble in May and bought pHisoDerm from Sterling for $16 mil. in June.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning